Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Advanced Biomed Inc. (ADVB) vs bioAffinity Technologies, Inc. (BIAF)

Advanced Biomed Inc. and bioAffinity Technologies, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $10.4M against $9.0M — 1.2× the size. bioAffinity Technologies, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 1.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −257.3%) and the higher return on invested capital (−29.3% vs −408.7%). Across the 13 metrics below, Advanced Biomed Inc. leads on 10 and bioAffinity Technologies, Inc. on 3.

Valuation

Metric ADVB BIAF Diagnostics & Research median
P/E 1.35 n/m 33.95
P/S n/m 0.47 4.87
P/B 0.91 0.73 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales n/m 0.15 5.66
Earnings yield 74.15% (1,380.14%) (1.75%)
Free cash flow yield (35.24%) (418.18%) (0.13%)

Profitability

Metric ADVB BIAF Diagnostics & Research median
Gross margin — 34.61% 50.89%
Operating margin 0.00% (209.82%) (8.57%)
Net margin 0.00% (257.33%) (6.37%)
Free cash flow margin 0.00% (195.90%) 0.00%
Return on equity 79.17% (1,860.15%) (2.92%)
Return on assets 55.78% (245.51%) (6.71%)
Return on invested capital (29.27%) (408.67%) 0.00%

Growth

Metric ADVB BIAF Diagnostics & Research median
Revenue growth (TTM) — (23.18%) 7.69%
EPS growth (last fiscal year) (15.01%) 61.55% —
Revenue growth, 5-year CAGR — — 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB BIAF Diagnostics & Research median
Debt to equity 0.00 0.15 0.11
Current ratio 7.38 1.44 2.02
Net debt to EBITDA 1.08 0.57 0.78

Dividend

Metric ADVB BIAF Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — — 0.00

Size

Metric ADVB BIAF Diagnostics & Research median
Market cap 10.42m 9.00m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack